1374 companies

Bioventix

Market Cap: UK£129.3m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

BVXP

UK£24.75

7D

1.6%

1Y

-34.9%

Bliss GVS Pharma

Market Cap: ₹15.3b

Engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally.

506197

₹145.10

7D

-3.6%

1Y

8.2%

Wuhan YZY Biopharma

Market Cap: HK$1.3b

A biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases.

2496

HK$6.80

7D

11.8%

1Y

14.9%

Coherus Oncology

Market Cap: US$168.5m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

CHRS

US$1.50

7D

-6.8%

1Y

42.9%

AFT Pharmaceuticals

Market Cap: NZ$291.5m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFT

NZ$2.78

7D

6.1%

1Y

-12.0%

BIOBIJOULtd

Market Cap: ₩236.0b

Engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea.

A489460

₩15,690.00

7D

-4.0%

1Y

n/a

Enanta Pharmaceuticals

Market Cap: US$165.7m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

ENTA

US$7.90

7D

3.4%

1Y

-21.4%

Protara Therapeutics

Market Cap: US$165.5m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

TARA

US$4.25

7D

33.2%

1Y

124.9%

Kwang Dong Pharmaceutical

Market Cap: ₩231.0b

Operates as a human healthcare provider in South Korea.

A009290

₩5,880.00

7D

-0.5%

1Y

-0.5%

MaxCyte

Market Cap: US$163.1m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

MXCT

US$1.53

7D

0.7%

1Y

-60.5%

AVITA Medical

Market Cap: US$162.5m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL

US$5.20

7D

-4.9%

1Y

-51.6%

Jagsonpal Pharmaceuticals

Market Cap: ₹14.3b

Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.

JAGSNPHARM

₹214.95

7D

-11.6%

1Y

29.6%

Eledon Pharmaceuticals

Market Cap: US$161.1m

Operates as a clinical stage biotechnology company.

ELDN

US$2.69

7D

5.5%

1Y

8.0%

Scilex Holding

Market Cap: US$160.6m

Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.

SCLX

US$29.21

7D

0.4%

1Y

-11.3%

Cenra

Market Cap: NT$4.9b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

3716

NT$33.50

7D

0.1%

1Y

-16.0%

Genovis AB (publ.)

Market Cap: SEK 1.5b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

GENO

SEK 22.65

7D

-1.5%

1Y

-19.5%

JW Holdings

Market Cap: ₩224.5b

Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.

A096760

₩3,245.00

7D

-3.1%

1Y

3.5%

OSE Immunotherapeutics

Market Cap: €135.1m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

OSE

€5.88

7D

3.9%

1Y

-27.9%

Genelux

Market Cap: US$157.2m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

GNLX

US$4.20

7D

1.0%

1Y

93.5%

Aroa Biosurgery

Market Cap: AU$239.8m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.69

7D

3.7%

1Y

26.4%

Adocia

Market Cap: €133.1m

A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.

ADOC

€7.30

7D

-3.9%

1Y

26.7%

BICO Group

Market Cap: SEK 1.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

BICO

SEK 20.66

7D

-1.9%

1Y

-53.2%

StemCyte International

Market Cap: NT$4.7b

Operates cord blood cell banks in the United States and Taiwan.

4178

NT$24.60

7D

0.4%

1Y

n/a

Sunho Biologics

Market Cap: HK$1.2b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems.

2898

HK$7.96

7D

3.4%

1Y

53.7%

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.2b

Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.

8049

HK$2.14

7D

-1.4%

1Y

62.1%

Photocure

Market Cap: NOK 1.5b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

PHO

NOK 57.60

7D

-2.9%

1Y

9.7%

Actuate Therapeutics

Market Cap: US$152.4m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

ACTU

US$6.89

7D

3.8%

1Y

9.9%

Avalo Therapeutics

Market Cap: US$151.9m

A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

AVTX

US$10.80

7D

-8.7%

1Y

14.9%

Achieve Life Sciences

Market Cap: US$151.8m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

ACHV

US$3.01

7D

6.7%

1Y

-36.9%

Cassava Sciences

Market Cap: US$149.8m

A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

SAVA

US$2.99

7D

31.1%

1Y

-89.5%

Amicogen

Market Cap: ₩211.0b

Operates as an industrial biotechnology company in South Korea and internationally.

A092040

₩3,850.00

7D

-3.8%

1Y

-16.8%

Corbus Pharmaceuticals Holdings

Market Cap: US$148.8m

A biopharmaceutical company, develops products to defeat serious illness.

CRBP

US$12.11

7D

5.3%

1Y

-42.1%

Formosa Pharmaceuticals

Market Cap: NT$4.5b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

6838

NT$30.05

7D

-2.0%

1Y

-31.5%

Kotra Industries Berhad

Market Cap: RM 627.4m

An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.

KOTRA

RM 4.23

7D

-0.7%

1Y

-4.1%

Cybin

Market Cap: US$147.7m

A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

CYBN

US$5.86

7D

-2.3%

1Y

-39.0%

SunWay Biotech

Market Cap: NT$4.5b

Focuses on professional research and development, and technical material manufacturing and processing business.

1271

NT$74.50

7D

0.7%

1Y

-11.9%

Page 21 of 39